Sciences of Pharmacy
Open Access

Sciences of Pharmacy

sciphar@etflin.com (Managing Editor)
Preclinical and clinical drug developmentDrug deliveryPharmaceutical formulationPharmacodynamicsPharmacokineticsDrug metabolismPharmacogeneticsGene-based therapyCell-based therapyProtein-based therapyDrug classesDrug nomenclatureDrug-drug interactionAdverse drug reactionDrug toxicityPharmacovigilancePharmacoepidemiologyPharmacoeconomicsClinical pharmacy

Official Affiliation

Affiliation logo

Volume 2 Issue 4

Showing 5 Articles

RESEARCH ARTICLE

  • Alpha Lipoic Acid Improves Memory and Antioxidant Enzymes Activity in Diabetic Wistar Rats
    research article

    Alpha Lipoic Acid Improves Memory and Antioxidant Enzymes Activity in Diabetic Wistar Rats

    Usman Adamu Garkuwa, Malajiya Ibrahim Alhaji Saleh, Abdulwahab Alhassan, Mohammed Umaru Kawu

    Diabetes mellitus (DM) and oxidative stress are among the leading causes of memory loss and dementia. Dietary supplements have been used to manage many disorders. This research aimed to determine the effect of alpha lipoic acid (ALA) on memory and oxidative stress in diabetic Wistar rats. 30 rats were grouped into six (5 in each). Diabetes was induced using a high-fat diet followed by a single low dose of streptozotocin (40 mg/kg) intraperitoneally. Group I served as normoglycemic control (1 mL/kg normal saline), while groups II, III, IV, V, and VI were diabetic and received 1 mL/kg at normal saline, glibenclamide at 1 mg/kg, ALA at 100 mg/kg, 200 mg/kg and 400 mg/kg respectively for 21 days. Blood glucose level was determined before and after treatment. Long-term and recognition memory were determined using novel object recognition tasks (NORT). Brain tissues were used for antioxidant enzymes. The result obtained showed that at 400 mg/kg after 21 days of administration of ALA, long-term memory and recognition ability were increased significantly (45.65 ± 3.43s and 83.77 ± 1.49%) compared to the diabetic control (26.24 ± 3.81s and 65.09 ± 2.52%) respectively. Antioxidant enzymes’ levels were increased significantly in the group VI including catalase (1.76 ± 0.02 IU/mg) superoxide dismutase (1.02 ± 0.71 IU/mg) and reduced glutathione (91.08 ± 3.49 µg/mL) compared to the diabetic control group (0.84 ± 0.03 IU/mg, 0.49±0.03 IU/mg and 51.64 ± 0.87 µg/mL) respectively. The findings suggest that ALA has antioxidant activity and improves memory in diabetic Wistar rats.

    Sciences of Pharmacy

    2 Oct 2023
    9 pages
  • Viability of Lactobacillus acidophilus in Effervescent Granules Prepared via Wet Granulation Method: In Vitro Study
    research article

    Viability of Lactobacillus acidophilus in Effervescent Granules Prepared via Wet Granulation Method: In Vitro Study

    Reza Pratama, Kholifa Nisya Melinda, Soni Muhsinin

    Lactobacillus acidophilus, a strain of lactic acid bacteria widely used as a probiotic microorganism, has been extensively employed in developing probiotic products including in effervescent granules. This study's objectives were to ensure that the resultant granules possessed the desired physical attributes and retained the requisite viability of lactic acid bacteria. A wet granulation method was used. The formula was physically evaluated and analyzed using Design Expert software, followed by gram staining and bacterial harvesting. Gram staining verification demonstrated the gram-positive nature of the pure L. acidophilus bacterial isolates, as evidenced by their consistent purple coloration and characteristic basil shape. Evaluation of physical properties revealed organoleptic attributes such as granular shape, white coloration devoid of odor, flow rate of 1.497 g/sec, an angle of repose at 40.75o, compressibility of 11.45%, drying loss of 0.62%, and a foam height of 3.075 cm, consistently meeting the stipulated criteria. Furthermore, formula I, II, and III preserved L. acidophilus bacteria after being converted into effervescent granules, as evidenced by viable lactic acid bacteria counts, with formula I (412.5 x 101 cfu/g), formula II (422.7 x 101 cfu/g), and formula III (highest at 522.7 x 101 cfu/g). The formula I emerges as the most favorable effervescent granules containing L. acidophilus 3%; polyvinylpyrrolidone 3%; citric acid 0.3%; tartaric acid 49.7%; sodium bicarbonate 25% and lactose as filler. Based on the finding, this probiotic effervescent granules has the potential to be developed as a daily supplement, especially for flora normal stabilization.

    Sciences of Pharmacy

    25 Nov 2023
    11 pages
  • research article

    Identification of Antioxidant Compounds in Fig Leaves (Ficus carica L) Fractions Using LC-MS/MS

    Rahmatul Qodriah, Shirly Kumala, Syamsudin Syamsudin, Nancy Dewi Yuliana, Partomuan Simanjuntak, Ervina Putri

    The fig plant (Ficus carica L.) is one of the most popular ficus genera and is spread in tropical and sub-tropical regions throughout the world. Fig leaves have potential as antioxidants. The purpose of this study was to identify antioxidant compounds in the ethanol extract of fig leaves of the Iraqi variety. The research involved preparing extracts by maceration using 96% ethanol, 70% ethanol, and 50% ethanol, testing antioxidant activity and identifying their chemical structures using LC-MS/MS. Based on the results of the antioxidant activity test using the DPPH free radical scavenging method, it was shown that the 50% ethanol extract of fig leaves had a very strong antioxidant activity with an IC50 value of 23.36 µg/mL. The results of identification with LC-MS/MS, it is estimated that the compound that has the potential as an antioxidant in the fig leaves of the Iraqi variety is the kaempferol compound.

    Sciences of Pharmacy

    9 Nov 2023
    7 pages
  • Potential Drug Interactions in Inpatients with Chronic Kidney Disease at Undata Hospital, Palu City, Indonesia
    research article

    Potential Drug Interactions in Inpatients with Chronic Kidney Disease at Undata Hospital, Palu City, Indonesia

    Indah Kurnia Utami, Niluh Puspita Dewi, Syafika Alaydrus, Magfirah Magfirah, Musfirah Musfirah, Nur Azizah

    Patients with Chronic Kidney Disease (CKD) often receive a combination of medications, which can have beneficial effects but may also lead to ineffective treatment. The objective of this study was to analyze potential drug interactions in CKD patients admitted to the Seroja ward at Undata Hospital in Palu, Central Sulawesi Province, during the year 2022. The study was conducted prospectively from July 20 to September 18, 2022, involving a total of 40 patients. The research utilized a non-experimental observational design, and the results were presented descriptively using purposive sampling based on predefined criteria. Drug interaction were screened using the Drug Interaction Checker tool. The study revealed that among CKD patients, a higher percentage of men (55%) than women (44%) were observed, with the highest percentage in the age group of 46–55 (27.5%). The most commonly drug group used was loop diuretics and furosemide (18.75%). The most significant potential drug interactions were pharmacodynamic interactions (12.5% in 5 cases) with minor significance, followed by pharmacokinetic interactions (2.5% in 1 case) with major significance, particularly in the use of calcium channel blockers (CCBs) and statins. Based on the findings, minor interaction cases do not always yield negative outcomes. In certain clinical practices, these interactions are intentionally utilized to achieve favorable results. Instances of major interactions with drug use should be avoided, and alternative drugs should be considered. In urgent situations where the drug is necessary, restrictions can be applied, and close monitoring of the patient's clinical status is vital.

    Sciences of Pharmacy

    26 Nov 2023
    6 pages
  • Risk Factors and Adverse Drug Reactions in HIV/AIDS Patients at Undata Regional Hospital in Palu City, Indonesia
    research article

    Risk Factors and Adverse Drug Reactions in HIV/AIDS Patients at Undata Regional Hospital in Palu City, Indonesia

    Ayu Wulandari, Dian Rahmawati, Utami Islamiati, Ficanata Adiguna Toding, Muflihatun Muflihatun

    AIDS (acquired immunodeficiency syndrome) is a clinical manifestation of the late stage of HIV infection (human immunodeficiency virus). This virus attacks CD4 cells in the immune system which is an important component in fighting infection. Without treatment, HIV can gradually destroy the immune system and lead to AIDS. This study aims to identify risk factors and determine and identify the type of ADR in HIV/AIDS patients at Undata Regional General Hospital Palu, Central Sulawesi province. This study used a cross-sectional observation method with prospective data collection, with a sample of 126 patients. Based on the results of the study, patients with HIV/AIDS had the most risk factors, namely homosexuality as many as 73 patients (58%), at the clinical stage, namely stage 3, 50 patients (39%), on opportunistic infection data, namely candidiasis, 35 patients (33%), and the initial CD4 cell count of <200 cells/mm3 in 27 patients (21%). Patients with HIV/AIDS who experienced ADR using antiretroviral drugs were 255 out of a total of 126 patients. Types of ADR that occur in HIV/AIDS patients include fever (6%), dizziness (47%), nausea (12%), vomiting (7%), insomnia (15%), easy hunger (1%), Hb low (1%), weakness (1%), rash (9%), headache (1%). Overall, these findings contribute valuable information for developing targeted interventions and improving the overall care and outcomes for individuals with HIV/AIDS.

    Sciences of Pharmacy

    29 Nov 2023
    7 pages

Journal Key Facts

Publishing Fee (APC)

IDR 1100000

Open Access License

CC BY 4.0

Language

English

Abstracting & Indexing
SintaCAS

Overview

Sciences of Pharmacy (SciPhar) is a peer-reviewed open-access journal of pharmacy owned and published by ETFLIN. We offer a platform and place for researchers and intellectuals, especially the youth, to share their insights and works. SciPhar accepts original article, reviews, mini-review, book-review, technical note, case report, case series, clinical trial, opinion/perspective, conference proceeding, and pictorial essay. Author may submit or suggest another type of scientific manuscript. Sciphar publishes 4 issues a year. Sciences of Pharmacy is affiliated with Faculty of Pharmacy, Universitas Islam Sultan Agung.

Authors from countries other than Indonesia are not charged a publication fee until further notice.

Published 4 issues a year (March, June, September and December) with a continuous publishing model — accepted articles are immediately assigned to the active issue.
Eligible Article Types: Case Report, Case Series, Clinical Trial, Editorial, Letter to Editor, Meta Analysis, Mini Review, Opinion/Perspective, Research Article, Review, Technical Note
Current Issue

Latest Articles

Recently published research articles, review papers, and technical notes from the current volume of the journal.

  • research article

    Griess Assay Evaluation of Nitric Oxide Scavenging by a Multi-Extract Emulgel for Topical Steroid Withdrawal

    Wahyu Bachtiar, Tyssa Mariyana, Nurul Hidayatri, Bheta Sari Dewi, Ayu Werawati

    Topical steroid withdrawal (TSW) is an iatrogenic dermatosis following prolonged topical corticosteroid use, with limited non-steroidal alternatives. This study developed a multi-extract emulgel containing Andrographis paniculata, Tinospora cordifolia, Curcuma longa, and Piper nigrum and screened its nitric oxide (NO)-scavenging activity. Standardized ethanolic extracts were incorporated into eight emulgels (F1–F8) using a 2³ full factorial design, varying A. paniculata (3–5%), T. cordifolia (4–6%), and C. longa (4–6%) with P. nigrum fixed at 10%. Physical characterization showed homogeneous oil-in-water emulgels with pH 5.26–5.90, spreadability 6.7–6.8 cm, and viscosity 12,560–17,120 cP. IC₅₀ values for all formulations exceeded the highest tested concentration (100 µg/mL) without reaching the concentration-response curve plateau, and are reported as > 100 µg/mL compared to 18.48 µg/mL for ascorbic acid. Descriptive ranking placed F4 first, followed by F7 and F8. Exploratory factorial analysis indicated that C. longa levels and the A. paniculata × T. cordifolia interaction drove IC₅₀ variation, showing that higher extract loading did not enhance activity. Because this cell-free assay reflects only direct chemical NO scavenging, findings are strictly preliminary and descriptive. Future validation requires independent runs across an expanded concentration range capturing the full upper plateau. F4 is tentatively proposed as the lead formulation for confirmatory testing and subsequent stability, cell-based, and in vivo studies.

    Sciences of Pharmacy

    1 Nov 2026
    16 pages
  • review

    Solid Lipid Nanoparticles as Delivery Systems for Plant-Derived Phytochemicals in Cancer Therapy: A Systematic Review

    Ade Abiyyatun Mahdiyyah, Mazaya Fadhila, Moh. Firman Irwanto, Ayu Rana Esadini, Wafa Wafa, Alfa Frista Arta, Ira Novita Sari

    Solid lipid nanoparticles (SLNs) have been investigated as lipid-based delivery systems to improve the solubility, stability, bioavailability, and delivery of plant-derived phytochemicals to tumors for cancer therapy. However, the available evidence remains heterogeneous and predominantly preclinical. This systematic review aimed to evaluate the formulation strategies, physicochemical characteristics, and therapeutic applications of phytochemical-loaded SLNs in cancer therapy. The review followed the PRISMA 2020 guidelines. Original research articles in English investigating phytochemical-loaded SLNs for cancer therapy were included. Data on formulation composition, preparation methods, physicochemical properties, drug release, in vitro anticancer activity, pharmacokinetics, biodistribution, and in vivo antitumor efficacy were extracted. Risk of bias was assessed using the SYRCLE tool for animal studies and an adapted checklist for in vitro studies. Thirty one articles were included in the qualitative synthesis. Most SLNs had particle sizes in the nanoscale range, approximately 50-350 nm, with encapsulation efficiencies of 43-99% and sustained-release profiles. Encapsulation generally improved cellular uptake and in vitro cytotoxicity in several cancer models. However, evidence of improved bioavailability, active tumor targeting, and in vivo antitumor efficacy remained limited and heterogeneous. Surface modification enhanced cellular uptake or organ accumulation in some studies, but validated tumor-specific targeting was not consistently demonstrated. Overall, phytochemical-loaded SLNs demonstrate potential as delivery platforms; however, clinical translation requires standardized formulations, robust in vivo studies, comprehensive safety evaluations, and clinical trials.

    Sciences of Pharmacy

    7 Nov 2026
    19 pages
  • research article

    Solid Preservative Preparation from Decolorized Ethanolic Extract of Ginggiang (Leea aequata L.): A 90-Day Subchronic Toxicity Study in Rats

    Purwaniati Purwaniati, Rahmana Emran Kartasasmita, Maria Immaculata Iwo, Muhamad Insanu

    Natural preservatives derived from medicinal plants require a thorough safety evaluation before they can be used in food. Ginggiang has traditionally been used by the Kuta indigenous community in Ciamis, West Java, Indonesia, to preserve palm sap; however, its safety profile has not been evaluated. In this study, a solid preservative preparation was developed from the decolorized ethanolic extract of ginggiang leaves (SPP-ED), and its safety profile was assessed after repeated oral administration. The study focused on subchronic oral toxicity and identified the target organs affected by repeated exposure to SPP-ED. In a 90-day experiment, both male and female Wistar rats received SPP-ED at doses of 45, 150, or 1500 mg/kg body weight per day. Satellite groups were included to evaluate recovery. Various parameters, including behavioral, hematological, biochemical, urinalysis, organ index, and histopathological evaluations, were systematically analyzed. No mortality was observed during the study. The results showed that subchronic exposure to SPP-ED had sex-specific effects: female rats experienced renal alterations, characterized by changes in urinalysis, elevated blood urea nitrogen and creatinine levels, and signs of tubular degeneration. In contrast, male rats exhibited pulmonary changes, including an increased lung-to-body weight ratio, alveolitis, and fibrosis. The D1 dose (45 mg/kg body weight/day) was the lowest dose at which potentially adverse histopathological changes were observed; however, a definitive NOAEL and LOAEL could not be established. Further studies using lower dose levels are warranted to better characterize the dose-response relationship and establish the NOAEL and LOAEL of SPP-ED.

    Sciences of Pharmacy

    2 Nov 2026
    13 pages
  • research article

    Polypharmacy and Potentially Inappropriate Medications (PIMs) in Older Adults with Cardiometabolic Disease: A STOPP/START Criteria-Based Analysis

    Yeni Farida, Rizki Amalia Taufany

    Potentially inappropriate medications (PIMs) are a common issue in older adults. Older adults often require multiple medications to manage cardiometabolic disease. This study aimed to identify potentially inappropriate medications and potential inappropriate omissions using STOPP/START criteria in older adult patients with cardiometabolic disease. We conducted an observational analytical study using retrospective data at a secondary care teaching hospital in Sukoharjo, Central Java. We included older adult patients admitted to the inpatient wards between January and June 2022. The prescriptions were analyzed using the STOPP/START Criteria 2016. The Chi-square test analysis was performed to examine the association between the number of drugs and the occurrence of PIMs. We included 97 geriatric inpatients. All patients received at least 5 drugs during each admission, 35.06% were classified as having hyperpolypharmacy. Among the 97 patients, 36.08% had PIM prescriptions, and 29.89% had PPOs. There was a statistically significant association between the number of drugs and PIMs in older adults. Compared with patients receiving > 10 medications, those receiving 5–10 medications had lower odds of PIM use (OR 0.409, 95% CI 0.173–0.969; p = 0.040). These findings highlight high medication burden as an important marker for targeted medication review in geriatric inpatients, particularly those with cardiometabolic multimorbidity.

    Sciences of Pharmacy

    31 Oct 2026
    10 pages
  • research article

    Comparison of PEG 4000 and 6000 in Solid Dispersion of Tadalafil Prepared by Melting Method

    Moh. Firman Irwanto, Arif Budi Setianto, Ade Abiyyatun Mahdiyyah, Maratun Shoaliha, Amzal Mortin Andas, Ashar Prima, Indah Puspitasari, Andi Tenri Nurwahidah, Fauziah H Wada

    Tadalafil is a BCS Class II drug with very low aqueous solubility, limiting its oral bioavailability. Solid dispersion technology using polyethylene glycol (PEG) is an effective strategy to enhance solubility. This study aimed to compare the effectiveness of PEG 4000 and PEG 6000 as carriers in amorphous solid dispersions of tadalafil prepared by the melting method. Solid dispersions were prepared at weight ratios (tadalafil:polymer) of 1:1, 1:2, 1:3, and 1:4 for both PEG 4000 and PEG 6000 using the fusion technique (70 °C). The formulations were characterized by Powder X-Ray Diffraction (PXRD), Differential Scanning Calorimetry (DSC), and Fourier Transform Infrared (FTIR) spectroscopy. Solubility studies were conducted in distilled water and phosphate buffer (pH 6.8) and analyzed via a validated HPLC method. Solid dispersions with PEG 6000 at a 1:3 ratio (F7) exhibited the highest solubility enhancement, reaching 16.08 ± 0.6 µg/mL in water. For PEG 4000, the 1:2 ratio (F2) was optimal (8.20 ± 1.3 µg/mL). PXRD and DSC analyses confirmed the transformation of crystalline tadalafil into an amorphous state within the polymer matrix. FTIR spectra indicated shifts in N-H and C=O bands, suggesting hydrogen bond formation. In conclusion, PEG 6000 produced a superior solid dispersion for tadalafil compared to PEG 4000. The primary mechanism is the formation of an amorphous system stabilized by hydrogen bonding. This study provides a formulation basis for improving the oral delivery of tadalafil.

    Sciences of Pharmacy

    2 Nov 2026
    9 pages